Table 4 AIC values to compare prognostic models for progression-free survival for 166 non-squamous carcinoma patients with available mutation status of KRAS and STK11 genes.

From: Development of a prognostic multiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first line immunotherapy

Model

AIC value

Multiomic graph clinical model

947.5

Combination clinical model

952.3

Clinical model

960.4

Back to article page